Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2026, Vol. 58 ›› Issue (1): 190-195. doi: 10.19723/j.issn.1671-167X.2026.01.025

Previous Articles     Next Articles

Analysis of early complications and risk factors in patients with amyotrophic lateral sclerosis after percutaneous endoscopic gastrostomy

Xueli TIAN1, Zhiqiang SONG1, Yonghui HUANG2,*(), Wei YAO1   

  1. 1. Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Gastroenterology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China
  • Received:2025-05-26 Online:2026-02-18 Published:2025-08-27
  • Contact: Yonghui HUANG

RICH HTML

   

PDF (PC)

Abstract:

Objective: To explore risk factors of early complications (≤14 days) and the clinical characteristics in patients with amyotrophic lateral sclerosis (ALS) after percutaneous endoscopic gastrostomy (PEG). Methods: Patients diagnosed with ALS who underwent first PEG insertion between January 2011 and December 2020 were eligible. Medical records were retrospectively reviewed to determine clinical characteristics and outcomes (≤14 days) of patients who underwent the pull type PEG. Grouping was performed based on the presence and severity of complications, and SPSS 27.0 statistical software was used for data analysis. Finally, Logistic regression model was applied for multivariate factor analysis of risk factors related to complications. Results: In the study, 192 cases of PEG were all successfully completed, with 97 (51%) males, mean age of ALS onset disease (55±11) years and 93 (48%) bulbar onset symptoms included. Complications occurred in 40 (21%) cases after PEG within 14 days, all of which had fever, including 16 cases without clear infection focus, 18 cases of respiratory tract infections, and 6 cases of fistula site infections. In the study, 13 (7%) cases had major complications, including 11 cases of respiratory tract infection and 2 cases of stoma infection. Two cases of respiratory tract infection died due to respiratory failure, and the remaining 11 cases recovered after upgraded antibiotic. No complications, such as tube dislodgement, benign pneumoperitoneum, hemorrhage or buried bumper syndrome occurred. The operation time and postoperative hospital stay were longer in the complication group than in the non-complication group [(16±5) min vs. (13±5) min, P < 0.001; 6 (5, 9) d vs. 5 (3, 7) d, P=0.009]. Compared with the mild complication group, the creatinine and triglyceride in the major complication group were significantly lower [(46.5±16.2) μmol/L vs.(66.8±16.4) μmol/L, P＜0.001; (1.1±0.5) mmol/L vs.(1.6±0.7) mmol/L, P=0.038], and the operation time was significantly longer [(20±5) min vs. (15±5) min, P=0.002]. Further, Logistic regression model analysis revealed that the operation time was also independent associated with complications (OR=1.132, 95%CI: 1.051-1.220, P=0.001). Conclusion: PEG was a reliable method for ALS patients to put nutrition tube. Postoperative fever was the most common complications. Long surgical duration was an independent risk factor for the occurrence of complications (≤14 d).

Key words: Amyotrophic lateral sclerosis, Gastrostomy, Factor analysis, statistical, Complications

CLC Number: 

  • R744.8

Figure 1

Percutaneous endoscopic gastrostomy (PEG) using the pull technique A, puncture needle with plastic sheath into abdominal and gastric walls; B, the needle was removed and the guide wire was inserted through the plastic sheath; C, biopsy forceps grasping guidewire through the endoscopic channel; D, PEG tube was placed by the pull technique using an internal bumper."

Table 1

Complications after PEG tube placement within 14 days"

Complications within 14 days n
Minor complications
  Post-operative fever (prophylactic antibiotics) 27
    Without evident infection 16
    Respiratory tract infection 7
    Peristomal wound infection 4
  Tube dislodgement 0
  Benign pneumoperitoneum 0
Major complications
  Post-operative fever (upgraded antibiotics)) 13a
    Respiratory tract infection 11a
    Peristomal wound infection 2
  Hemorrhage 0
  Injury to internal organs 0
  Buried bumper syndrome 0
  Respiratory failure 2a
  Death 2a

Table 2

Descriptive statistics and bivariate comparisons of patients who had complication vs. non-complication"

Items Complication (n=46) Non-complication (n=146) Statistics (χ2/t/z) P
Male, n (%) 25 (54) 72 (49) 0.354 0.552
Site of disease onset (bulbar), n (%) 21 (46) 72 (49) 0.188 0.665
Age at disease onset /years, $\bar x \pm s$ 54±11 56±12 0.897 0.572
Diagnose delay/months, M (P25, P75) 12 (7, 18) 12 (6, 24) －0.192 0.848
ALSFRS, $\bar x \pm s$ 24±10 24±10 －0.247 0.805
Interval from disease onset to PEG/months, M (P25, P75) 25 (17, 39) 26 (18, 40) －0.329 0.742
Laboratory data, $\bar x \pm s$
  Albumin/(g/L) 41.5±4.1 41.2±3.2 0.512 0.610
  Creatinine/(μmol/L) 61.0±18.6 60.0±18.0 0.327 0.744
  Sodium/(mmol/L) 140.5±2.4 139.9±8.9 0.388 0.698
  Potassium/(mmol/L) 3.8±0.3 3.9±0.3 －1.247 0.214
  Triglyceride/(mmol/L) 1.5±0.7 1.3±0.6 1.442 0.223
Transnasal gastroscopy, n (%) 34 (73) 107 (73) 0.007 0.933
Operation time/min, $\bar x \pm s$ 16±5 13±5 3.606 0.000
Hospital days, M(P25, P75) 6 (5, 9) 5 (3, 7) 2.692 0.009

Table 3

Descriptive statistics and bivariate comparison of patients who had minor complication vs. major complication"

Items Minor complication (n=33) Major complication (n=13) Statistics (χ2/t/z) P
Male, n (%) 20 (61) 5 (39) 1.843 0.175
Site of disease onset (bulbar), n (%) 18 (55) 3 (23) 3.722 0.054
Age at disease onset/years，$\bar x \pm s$ 56±12 51±10 1.368 0.178
Diagnose delay (months), M (P25, P75) 12 (9, 20) 11 (5, 18) -0.880 0.379
ALSFRS，$\bar x \pm s$ 25±10 23±11 0.438 0.664
Interval from disease onset to PEG/months, M (P25, P75) 25 (15, 35) 25(19, 65) －1.000 0.317
Laboratory data, $\bar x \pm s$
  Albumin/(g/L) 42.2±3.3 39.6±5.4 1.915 0.062
  Creatinine/(μmol/L) 66.8±16.4 46.5±16.2 3.788 0.000
  Sodium/(mmol/L) 140.7±2.6 139.9±1.7 1.004 0.321
  Potassium/(mmol/L) 3.8±0.3 3.9±0.4 －0.889 0.379
  Triglyceride/(mmol/L) 1.6±0.7 1.1±0.5 2.148 0.038
Transnasal gastroscopy, n (%) 24 (73) 10 (77) N/A >0.999
Operation time/min, $\bar x \pm s$ 15±5 20±5 －3.336 0.002
Hospital days, M(P25, P75) 6 (5, 8) 5 (4, 14) －0.841 0.400

Table 4

Multivariate analysis of risk factors related complications"

Predictors OR 95%CI P
Site of disease onset 0.889 0.406－1.946 0.769
Albumin 1.020 0.907－1.146 0.743
Creatinine 0.727 0.975－1.018 0.727
Triglyceride 1.453 0.834－2.532 0.187
Operation time 1.132 1.051－1.220 0.001
1
Rizea RE , Corlatescu AD , Costin HP , et al. Understanding amyotrophic lateral sclerosis: Pathophysiology, diagnosis, and therapeutic advances[J]. Int J Mol Sci, 2024, 25 (18): 9966.
2
Feldman EL , Goutman SA , Petri S , et al. Amyotrophic lateral sclerosis[J]. Lancet, 2022, 400 (10360): 1363- 1380.
3
Castanheira A , Swash M , De Carvalho M . Percutaneous gastrostomy in amyotrophic lateral sclerosis: A review[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2022, 23 (3/4): 176- 189.
4
Mendes I , Vara-Luiz F , Palma C , et al. Percutaneous endoscopic gastrostomy in the 21st century: An overview of 1415 consecutive dysphagic adult patients[J]. Nutrients, 2025, 17 (5): 747.
5
Farag M , Coleman A , Knights H , et al. Outcomes of percutaneous endoscopic gastrostomy in Huntington ' s disease at a tertiary center[J]. Mov Disord Clin Pract, 2024, 11 (8): 998- 1007.
6
Meine MC , Tusato IH , Hoffmeister N , et al. Percutaneous radiologic gastrostomy versus percutaneous endoscopic gastrostomy for enteral feeding: A systematic review and meta-analysis[J]. JPEN J Parenter Enteral Nutr, 2024, 48 (6): 667- 677.
7
Suzuki H , Joshita S , Nagaya T , et al. Relationship of early acute complications and insertion site in push method percutaneous endoscopic gastrostomy[J]. Sci Rep, 2020, 10 (1): 20551.
8
Pih GY , Na HK , Ahn JY , et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy insertion[J]. BMC Gastroenterol, 2018, 18 (1): 101.
9
Allen JA , Chen R , Ajroud-Driss S , et al. Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: A retrospective study of complications and outcome[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2013, 14 (4): 308- 314.
10
Gauderer MWL , Ponsky JL , Izant RJ . Gastrostomy without laparotomy: A percutaneous endoscopic technique[J]. J Pediatr Surg, 1980, 15 (6): 872- 875.
11
Carbó Perseguer J , Madejón Seiz A , Romero Portales M , et al. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis: Mortality and complications[J]. Neurol Engl Ed, 2019, 34 (9): 582- 588.
12
Elbe P , Markus K , Valente R , et al. Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis[J]. Minerva Gastroenterol Dietol, 2020, 66 (3): 219- 224.
13
Schrag SP , Sharma R , Jaik NP , et al. Complications related to percutaneous endoscopic gastrostomy (PEG) tubes. A comprehensive clinical review[J]. J Gastrointestin Liver Dis, 2007, 16 (4): 407- 418.
14
Tae CH , Lee JY , Joo MK , et al. Clinical practice guidelines for percutaneous endoscopic gastrostomy[J]. Clin Endosc, 2023, 56 (4): 391- 408.
15
Boeykens K , Duysburgh I , Verlinden W . Prevention and management of minor complications in percutaneous endoscopic gastrostomy[J]. BMJ Open Gastroenterol, 2022, 9 (1): e000975.
16
Conde B , Martins N , Rodrigues I , et al. Functional and endoscopic indicators for percutaneous endoscopic gastrostomy (PEG) in amyotrophic lateral sclerosis patients[J]. J Clin Med, 2018, 7 (10): 352.
17
Chang H , Huang Y , Yao W , et al. Improved method of gastrostomy tube replacement using a small-caliber transnasal endoscope[J]. Acta Oto Laryngol, 2016, 136 (2): 195- 198.
18
Lee C , Im JP , Kim JW , et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: A multicenter, retrospective study[J]. Surg Endosc, 2013, 27 (10): 3806- 3815.
19
Andersen PM , Abrahams S , Borasio GD , et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)-revised report of an EFNS task force[J]. Euro J Neurology, 2012, 19 (3): 360- 375.
20
Ljungqvist O , Weimann A , Sandini M , et al. Contemporary perioperative nutritional care[J]. Annu Rev Nutr, 2024, 44 (1): 231- 255.
21
Wills AM , Hubbard J , Macklin EA , et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled phase 2 trial[J]. Lancet, 2014, 383 (9934): 2065- 2072.
22
Bond L , Ganguly P , Khamankar N , et al. A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes[J]. Brain Sci, 2019, 9 (9): 223.
23
Fasano A , Fini N , Ferraro D , et al. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: A population-based registry study[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2017, 18 (3/4): 233- 242.
[1] Bo PENG, Fangfang LIU, Wei YANG, Ruiping XU, Lei CHEN, Baozhong LI, Xinjia WANG, Ji KE, Wenlei YANG, Yu HE, Zhen LIU, Bolin HOU, Liqun ZHANG, Miaoping LIN, Lixin ZHANG, Fan ZHANG, Fen CAI, Huawen XU, Mengfei LIU, Ying LIU, Yaqi PAN, Zhonghu HE, Yang KE. Perioperative hyperglycemia predicts poorer prognosis of esophageal squamous cell carcinoma patients treated with esophagectomy [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 567-574.
[2] Xiaolin WANG, Shaoyi GUO, Dazhao CHEN, Xijie WEN, Yong HUA, Liang ZHANG, Qin ZHANG. A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1081-1088.
[3] Chao ZUO, Guoli WANG, Kunlin YANG, Xinyan CHE, Yisen MENG, Kai ZHANG. Comparison of efficacy and safety of transurethral thulium fiber laser enucleation of prostate in patients with different prostate volumes [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 711-716.
[4] Zhao ZHAO, Weiyu ZHANG, Wenbo YANG, Yongjie ZHANG, Xiaopeng ZHANG, Huiying ZHAO, Gang ZHOU, Qiang WANG. Kidney transplantation in low-age, low-weight children: A report of two cases [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 803-807.
[5] Fei WANG, Xinyue ZHANG, Muqing LIU, Enbo WANG, Denghui DUAN. Clinical application and three-dimensional finite element analysis of along-axis extraction method in mandibular mesial and horizontally impacted third molar surgery [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 106-112.
[6] Liwei WANG, Bingchuan LIU, Yinyin QU, Changyi WU, Yun TIAN. Clinical application of multidisciplinary team in the diagnosis and treatment of chronic refractory wounds [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 185-191.
[7] Fangfei XIE, Hong QIAO, Boya LI, Cui YUAN, Fang WANG, Yu SUN, Shuangling LI. Severe malnutrition during pregnancy complicated with acute pyelonephritis causing sepsis, refractory septic shock and multiple organ failure: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 202-207.
[8] Li WAN, Zhoucang ZHANG, Jiaxiang DING, Mei WANG. Venous air embolism following removal of central venous catheters: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 938-941.
[9] Su-huan XU,Bei-bei WANG,Qiu-ying PANG,Li-jun ZHONG,Yan-ming DING,Yan-bo HUANG,Xin-yan CHE. Effect of equal temperature bladder irrigation in patients with transurethral resection of prostate: A meta-analysis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 676-683.
[10] Shan YE,Ping-ping JIN,Nan ZHANG,Hai-bo WU,Lin SHI,Qiang ZHAO,Kun YANG,Hui-shu YUAN,Dong-sheng FAN. Cortical thickness and cognitive impairment in patients with amyotrophic lateral sclerosis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1158-1162.
[11] Hui LI,Yang-xu GAO,Shu-lei WANG,Hong-xin YAO. Surgical complications of totally implantable venous access port in children with malignant tumors [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1167-1171.
[12] Bo YU,Yang-yu ZHAO,Zhe ZHANG,Yong-qing WANG. Infective endocarditis in pregnancy: A case report [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 578-580.
[13] LI Wei-hao,LI Wei,ZHANG Xue-min,LI Qing-le,JIAO Yang,ZHANG Tao,JIANG Jing-jun,ZHANG Xiao-ming. Comparison of the outcomes between open and hybrid approaches in the treatment of thoracoabdominal aortic aneurysms repair [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 177-181.
[14] Wen-min DONG,Ming-rui WANG,Hao HU,Qi WANG,Ke-xin XU,Tao XU. Initial clinical experience and follow-up outcomes of treatment for ureteroileal anastomotic stricture with Allium coated metal ureteral stent [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 637-641.
[15] Jian GAO,Li-bao HU,Chen CHEN,Xin ZHI,Tao XU. Interventional treatment of hemorrhage after percutaneous nephrolithotomy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 667-671.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd